Rip Road Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoodRx Holdings
GDRX
|
+$5.2M |
| 2 |
SIX
Six Flags Entertainment Corp.
SIX
|
+$3.24M |
| 3 |
SkinHealth Systems
SKIN
|
+$1.85M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$1.74M |
| 5 |
EWCZ
European Wax Center
EWCZ
|
+$1.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.49M |
| 2 |
Netflix
NFLX
|
+$1.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 31.84% |
| 2 | Consumer Discretionary | 26.54% |
| 3 | Consumer Staples | 19.98% |
| 4 | Industrials | 15.26% |
| 5 | Healthcare | 6.37% |
Similar funds
Rip Road Capital Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Rip Road Capital Partners held 12 positions worth $83.7M, up 26% from $66.6M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Rip Road Capital Partners deployed $10.9M of net new capital in Q2 2023, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was GoodRx Holdings: 966,100 shares worth $5.33M.
By sector, the portfolio is most concentrated in Communication Services at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Netflix, an estimated $1.44M trimmed.
- Rip Road Capital Partners's largest Q2 2023 buy was GoodRx Holdings: 966,100 shares worth $5.33M.
- Rip Road Capital Partners added most to SkinHealth Systems in Q2 2023, an estimated $1.85M increase.
- Rip Road Capital Partners's biggest Q2 2023 reduction was Netflix, cutting an estimated $1.44M.
- Rip Road Capital Partners fully exited Apple in Q2 2023, selling an estimated $2.49M.
- Rip Road Capital Partners's ten largest holdings make up 96% of its $83.7M portfolio in Q2 2023.
- Rip Road Capital Partners opened 2 new positions and closed 1 in Q2 2023.
- Rip Road Capital Partners's portfolio value rose 26% quarter-over-quarter to $83.7M.
Based on Rip Road Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.